Clin2
NCT07844954Possibly a fitNot yet recruiting

Patch safety study for healthy adults

Healthy Participants

This study tests whether a new skin patch, DM1001, is safe and how well the body tolerates it. It is for healthy adults who want to help find out if this patch could be used for future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
66 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in generally good health, without major medical conditions.
  • You weigh at least 110 pounds (50 kg) if you are male, or 99 pounds (45 kg) if you are female.
  • Your body mass index (BMI) is between 18 and 28.
  • You have not had recent skin problems or injuries where the patch would be placed.
  • You agree to avoid certain medications, alcohol, and other substances during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07232121Recruiting· Phase 1
Safety study of DF5112 in healthy adults

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Sydney, New South Wales
NCT06897813Not yet recruiting· Phase 1
Safety study of a new drug in healthy adults

This early-stage study tests a new investigational drug (called WD-910) in healthy volunteers to see how safe it is, how the body processes it, and how it affects the body. You would receive either the drug or a placebo (a pill with no active medicine), and doctors will monitor you closely.

Melbourne, Victoria
NCT07818330Not yet recruiting· Phase 1
Skin patch study for a sedative medicine

This study tests a new skin patch that delivers a medicine called dexmedetomidine, which is normally used for sedation, to see how safe it is when applied repeatedly. It is for healthy people and may help find a non-invasive way to give this medication.

NCT07240675Recruiting· Phase 1
First-in-human safety study of KLA478 in healthy volunteers

This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.

Shanghai, Shanghai Municipality
NCT07195851Not yet recruiting
Skin patch safety study for people with sensitive skin

This study tests how safe and well-tolerated a skin patch is on the back. It is for adults with sensitive skin who want to help evaluate a new cosmetic product.

NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.